Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1067

Lacto-N-neotetraose

Intended Use: Intended for use as an ingredient in nonexempt infant formula for term infants at a level up to 0.60 g/L; in formula for young children (> 12 months) at up to 0.6 g/L; in drinks for young children at up to 0.58 g/L; in foods for infants and young children at up to 3.0 g/kg; in sports, isotonic, and energy drinks; milk (unflavored and flavored), imitation milk, and buttermilk; and fruit juices and nectars at up to 0.58 g/L; in yogurt (including non-dairy yogurt) at up to 2.67 g/kg; in meal replacement drinks at up to 2.5 g/L; and in meal replacement bars at up to 20 g/kg.
Basis: Scientific procedures
Notifier: Inbiose N.V.
Notifier Address: Technologiepark Zwijnaarde 82 - bus 41
B-9052 Gent
Belgium
GRAS Notice (releasable information): GRN 1067 with amendments (in PDF) (7.6 MB)
Date of closure: Apr 4, 2023
FDA's Letter: FDA has no questions (in PDF) (306 kB)
-
-